Bank of America
IRON icon

Bank of America’s Disc Medicine IRON Stock Holding History

Bank of America’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.88M Sell
135,111
-31,664
-19% -$2.18M ﹤0.01% 3057
2026
Q1 		$10.7M Buy
166,775
+30,789
+23% +$2.14M ﹤0.01% 2898
2025
Q4 		$10.8M Sell
135,986
-25,198
-16% -$2.13M ﹤0.01% 2794
2025
Q3 		$10.7M Sell
161,184
-7,638
-5% -$454K ﹤0.01% 3232
2025
Q2 		$8.94M Buy
168,822
+115,014
+214% +$5.4M ﹤0.01% 3335
2025
Q1 		$2.67M Buy
53,808
+18,463
+52% +$1.03M ﹤0.01% 4415
2024
Q4 		$2.24M Sell
35,345
-34,747
-50% -$2.01M ﹤0.01% 4351
2024
Q3 		$3.44M Buy
70,092
+9,503
+16% +$446K ﹤0.01% 4086
2024
Q2 		$2.73M Sell
60,589
-153,102
-72% -$5.2M ﹤0.01% 4182
2024
Q1 		$13.3M Buy
213,691
+181,731
+569% +$11.8M ﹤0.01% 2676
2023
Q4 		$1.85M Sell
31,960
-21,863
-41% -$1.12M ﹤0.01% 4491
2023
Q3 		$2.53M Sell
53,823
-504,273
-90% -$25.2M ﹤0.01% 4043
2023
Q2 		$24.8M Buy
558,096
+555,414
+20,709% +$19.7M ﹤0.01% 1827
2023
Q1 		$56.8K Buy
2,682
+2,680
+134,000% +$59.7K ﹤0.01% 6464
2022
Q4 		$40 Sell
2
-6
-75% -$299 ﹤0.01% 7840
2022
Q3 		$0 Hold
8
– – ﹤0.01% 8012
2022
Q2 		$0 Sell
8
-230
-97% -$10.2K ﹤0.01% 8185
2022
Q1 		$10K Sell
238
-454
-66% -$23.8K ﹤0.01% 7742
2021
Q4 		$61K Buy
692
+315
+84% +$30.9K ﹤0.01% 7125
2021
Q3 		$45K Sell
377
-136
-27% -$18.6K ﹤0.01% 7099
2021
Q2 		$99K Buy
513
+397
+342% +$131K ﹤0.01% 6524
2021
Q1 		$47K Buy
+116
New +$51.7K ﹤0.01% 6654

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America's IRON Position: Q2 2026 in Review

Bank of America reduced its Disc Medicine (IRON) stake by 19% in Q2 2026, selling an estimated $2.18M and leaving 135,111 shares worth $9.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Bank of America first reported a position in IRON in Q1 2021 and has held it in 22 quarters since. The position peaked at $24.8M in Q2 2023. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Bank of America held 135,111 shares of Disc Medicine worth $9.88M as of Q2 2026.
  • Bank of America sold 31,664 Disc Medicine shares in Q2 2026, an estimated $2.18M.
  • Disc Medicine made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3057 holding.
  • Bank of America first reported a position in Disc Medicine in Q1 2021 and has held it in 22 quarters since.
  • Bank of America's Disc Medicine position peaked at $24.8M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.